Suppr超能文献

将微生物特征定义为克罗恩病患者内镜手术后复发的预测指标。

Definition of a microbial signature as a predictor of endoscopic post-surgical recurrence in patients with Crohn's disease.

作者信息

Oliver Lia, Camps Blau, Julià-Bergkvist David, Amoedo Joan, Ramió-Pujol Sara, Malagón Marta, Bahí Anna, Torres Paola, Domènech Eugeni, Guardiola Jordi, Serra-Pagès Mariona, Garcia-Gil Jesus, Aldeguer Xavier

机构信息

GoodGut S.L.U, Girona, Spain.

Hospital Universitari de Bellvitge, l'Hospitalet de Llobregat, Barcelona, Spain.

出版信息

Front Mol Med. 2023 Feb 3;3:1046414. doi: 10.3389/fmmed.2023.1046414. eCollection 2023.

Abstract

Although there are several effective drugs for the treatment of Crohn's disease (CD), almost 70% of patients will require surgical resection during their lifetime. This procedure is not always curative, as endoscopic recurrence occurs in 65%-90% of patients in the first year after surgery. The aetiology of the recurrence is unknown; however, several studies have shown how the resident microbiota is modified after surgery. The aim of this study was to evaluate samples from patients with Crohn's disease before and after an intestinal resection to determine whether there were differences in the abundance of different microbial markers, which may predict endoscopic recurrence at baseline. In this observational study, a stool sample was obtained from 25 patients with Crohn's disease before undergoing surgery, recruited at three Catalan hospitals. From each sample, DNA was purified and the relative abundance of nine microbial markers was quantified using qPCR. An algorithm composed of four microbial markers (, , , and ) showed a sensitivity and specificity of 90.91% and 85.71%, respectively, and a positive and negative predictive value of 83.33% and 92.31%, respectively. A microbial signature to determine patients who will have post-surgical recurrence was identified. This tool might be very useful in daily clinical practice, allowing the scheduling of personalized therapy and enabling preventive treatment only in patients who really require it.

摘要

尽管有几种有效的药物可用于治疗克罗恩病(CD),但几乎70%的患者在其一生中需要进行手术切除。该手术并不总是能治愈,因为65%-90%的患者在术后第一年就会出现内镜复发。复发的病因尚不清楚;然而,多项研究表明了术后常驻微生物群是如何改变的。本研究的目的是评估克罗恩病患者肠道切除术前和术后的样本,以确定不同微生物标志物的丰度是否存在差异,这些差异可能在基线时预测内镜复发。在这项观察性研究中,从加泰罗尼亚的三家医院招募了25名克罗恩病患者,在手术前采集了他们的粪便样本。从每个样本中纯化DNA,并使用qPCR对九种微生物标志物的相对丰度进行定量。由四种微生物标志物(、、和)组成的一种算法的敏感性和特异性分别为90.91%和85.71%,阳性预测值和阴性预测值分别为83.33%和92.31%。确定了一种用于判断术后复发患者的微生物特征。该工具在日常临床实践中可能非常有用,可用于安排个性化治疗,并仅对真正需要的患者进行预防性治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3744/11285546/c1df288343c5/fmmed-03-1046414-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验